Dr. Reddy’s selling anti-cancer agent to Citius Pharma
Set to receive $40 million upfront, approval milestone payment of upto $40 million later
Dr. Reddy’s Laboratories has entered into a definitive agreement with Citius Pharmaceuticals Inc pursuant to which it sold all rights to E7777 (an…